Range Low Price High Price Comment
30 days $0.782 $1.02 Wednesday, 1st May 2024 CTSO stock ended at $0.84. This is 3.79% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.69% from a day low at $0.81 to a day high of $0.86.
90 days $0.782 $1.06
52 weeks $0.782 $4.29

Historical Cytosorbents Corporation prices

Date Open High Low Close Volume
Feb 03, 2016 $3.96 $3.98 $3.61 $3.61 71 400
Feb 02, 2016 $3.91 $4.05 $3.90 $3.96 36 800
Feb 01, 2016 $3.83 $3.99 $3.67 $3.95 75 100
Jan 29, 2016 $3.65 $3.98 $3.58 $3.84 74 100
Jan 28, 2016 $3.91 $3.91 $3.62 $3.64 81 100
Jan 27, 2016 $3.94 $4.03 $3.81 $3.92 46 300
Jan 26, 2016 $3.92 $4.03 $3.80 $3.95 47 900
Jan 25, 2016 $4.02 $4.08 $3.83 $3.87 79 200
Jan 22, 2016 $4.06 $4.22 $3.96 $4.09 89 700
Jan 21, 2016 $4.15 $4.37 $4.03 $4.04 75 100
Jan 20, 2016 $4.01 $4.23 $3.50 $4.13 290 800
Jan 19, 2016 $4.30 $4.46 $4.03 $4.03 121 400
Jan 15, 2016 $4.23 $4.42 $4.15 $4.31 128 100
Jan 14, 2016 $4.27 $4.54 $4.26 $4.36 74 900
Jan 13, 2016 $4.89 $4.96 $4.06 $4.28 170 500
Jan 12, 2016 $4.81 $5.14 $4.80 $4.86 87 100
Jan 11, 2016 $4.97 $5.15 $4.59 $4.71 153 400
Jan 08, 2016 $4.70 $4.90 $4.61 $4.75 78 400
Jan 07, 2016 $5.00 $5.00 $4.50 $4.80 314 800
Jan 06, 2016 $5.49 $5.55 $5.15 $5.17 108 000
Jan 05, 2016 $5.83 $5.83 $5.47 $5.63 73 200
Click to get the best stock tips daily for free!

About Cytosorbents Corporation

Cytosorbents Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complication... CTSO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT